|
⚲
|
| Keyboard |
| Marques Tiago
✚
|
|
|---|---|
| CIK # | 0001875240 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001875240] | |
| 4 | [0001875240] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pasithea Therapeutics Corp | |
| Marques Tiago |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2025-11-28 | Buy | 33,333 | $0.75 | 25,000 |
|
Pasithea Therapeutics Corp KTTA
Stock Option (right to buy) · derivative
|
2025-10-24 | Grant | 493,341 | $0.00 | |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2025-05-12 | Sell | 960 | $0.83 | 797 |
|
Pasithea Therapeutics Corp KTTA
Stock Option (right to buy) · derivative
|
2024-03-01 | Grant | 11,669 | $0.00 | |
|
Pasithea Therapeutics Corp KTTA
Stock Option (right to buy) · derivative
|
2024-03-01 | Grant | 15,000 | $0.00 | |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-11-25 | Grant | 2,000 | $1.03 | 2,060 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-11-23 | Grant | 1,206 | $1.02 | 1,230 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-11-23 | Grant | 1,000 | $1.03 | 1,030 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-11-23 | Grant | 5,000 | $1.00 | 5,000 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-10-21 | Grant | 4,400 | $1.07 | 4,708 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-10-21 | Grant | 600 | $1.08 | 648 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-06-23 | Grant | 200 | $0.98 | 196 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-06-23 | Grant | 1,800 | $0.99 | 1,782 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-06-23 | Grant | 100 | $0.99 | 99 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2022-06-23 | Grant | 2,900 | $0.99 | 2,871 |
|
Pasithea Therapeutics Corp KTTA
Common Stock
|
2021-12-20 | Grant | 200,000 | $0.00 | |
|
Pasithea Therapeutics Corp KTTA
Stock Option (to acquire Common Stock) · derivative
|
2021-12-20 | Grant | 200,000 | $0.00 |